India tackles antimicrobial resistance crisis through innovative drug discovery

Summary: India faces a crisis with antimicrobial drug resistance, causing 4.9 million deaths globally in 2019. Researchers at CSIR-Centre for Cellular and Molecular Biology in Hyderabad identified potential drug targets in E. coli and Plasmodium falciparum. The drug discovery process involves finding inhibitors, assessing enzyme structures, and utilizing AI for molecule prediction. Collaboration across disciplines and industries is crucial for successful drug development. The road from target identification to drug approval is challenging but necessary.

Full article